Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEditor’s Page

Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage

Johannes Czernin
Journal of Nuclear Medicine January 2023, 64 (1) 1;
Johannes Czernin
David Geffen School of Medicine at UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

The observant reader might have noticed the absence of the Newsline section from the January 2023 issue of The Journal of Nuclear Medicine. Newsline, the “nonscientific” portion of JNM, covered leadership and policy updates, meeting information, literature updates, American Board of Nuclear Medicine news and other news briefs, and obituaries.

Newsline was created and led by Dr. Stanley Goldsmith from 1987 to 1999, by the late Dr. Conrad Nagle from 1999 to 2012, and by Dr. Harvey Ziessman from 2012 to 2022. Dr. Nancy Knight served as consulting editor starting in 1999. We extend our gratitude to these leaders for their exceptional contributions, for the quality of their work, and for their dedication to the JNM readership.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Johannes Czernin

Over the last couple of decades, news communications have accelerated dramatically via Twitter, LinkedIn, Facebook, and Instagram, among others. A monthly scientific publication simply cannot keep up with news cycles of a few hours.

Therefore, we are rededicating the Newsline space to publishing news-cycle–independent original research, invited perspectives, provocative editorials and informed commentaries, discussions with leaders, hot topics, issues and controversies, and letters to the editor and replies, as well as the transcribed and edited highlights lectures from the annual SNMMI meeting. Dr. Knight will continue as consulting editor to maintain continuity and high quality.

The entire JNM team thanks Drs. Harvey Ziessman and Nancy Knight for their valuable contributions.

We are confident that you, the reader, will enjoy the reformatted front section of The Journal of Nuclear Medicine.

  • © 2023 by the Society of Nuclear Medicine and Molecular Imaging.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (1)
Journal of Nuclear Medicine
Vol. 64, Issue 1
January 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage
Johannes Czernin
Journal of Nuclear Medicine Jan 2023, 64 (1) 1;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage
Johannes Czernin
Journal of Nuclear Medicine Jan 2023, 64 (1) 1;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study
  • Google Scholar

More in this TOC Section

  • Funding Reductions Threaten the Future of Medical Innovation
  • Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
  • The Costs to Our Patients
Show more Editor’s Page

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire